Breaking the $62 Billion Global Infection Crisis with DiviDiaper
Preventable infections and complications related to diapers and incontinence cost the world over $62 billion every year. DiviDiaper's revolutionary designs break the infection chain.
The Global Problem
Infant Impact
A significant percentage of infants experience diaper rash or incontinence-associated dermatitis (IAD), causing discomfort and potential complications.
Adult Impact
Many adults in care settings experience diaper rash or IAD, contributing to decreased quality of life and increased healthcare complexity.
$62 Billion Annual Cost
Global cost of preventable infections related to diapers and incontinence continues to strain healthcare systems worldwide.
Hospital-acquired infections (HAIs)—including sepsis, urinary tract infections (UTIs), and skin breakdown—are a massive burden on families, hospitals, and health systems worldwide[WHO][Sepsis Alliance].
Diaper Dermatitis & Incontinence-Associated Dermatitis
What is it?
Painful, inflamed skin caused by prolonged exposure to moisture, urine, and stool.
How common?
Up to 75% of infants and 25% of adults in care settings experience diaper rash or IAD.
Why it happens
Urine and stool mixing raises skin pH, activates enzymes, and damages the skin barrier. Fungal (Candida) and bacterial infections can develop in as many as 92% of severe cases[Medscape].
Catheter-Associated Urinary Tract Infection (CAUTI)
-
A catheter-associated urinary tract infection (CAUTI) occurs when germs (usually bacteria) enter the urinary tract via a urinary catheter, causing infection. CAUTIs are among the most common healthcare-associated infections (HAIs), accounting for up to 75% of hospital-acquired UTIs. About 15–25% of hospitalized patients receive urinary catheters, and prolonged catheter use is the single greatest risk factor for CAUTI
-
How common?
75% of hospital UTIs are catheter-associated[CDC].
-
Why it happens:
Catheters exposed to stool and bacteria dramatically increase infection risk.
-
How DiviDiaper helps:
Cathease™ isolates the catheter from stool and skin, reducing CAUTI risk by up to 75%[PMC11704929].
